Global Cord Blood (CORBF) Competitors $1.05 +0.10 (+10.53%) As of 04/24/2025 09:44 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CORBF vs. PSNL, VMD, DCGO, LFMD, TOI, SERA, AIRS, EUDA, QIPT, and BDSXShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Personalis (PSNL), Viemed Healthcare (VMD), DocGo (DCGO), LifeMD (LFMD), Oncology Institute (TOI), Sera Prognostics (SERA), AirSculpt Technologies (AIRS), EUDA Health (EUDA), Quipt Home Medical (QIPT), and Biodesix (BDSX). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Personalis Viemed Healthcare DocGo LifeMD Oncology Institute Sera Prognostics AirSculpt Technologies EUDA Health Quipt Home Medical Biodesix Global Cord Blood (NYSE:CORBF) and Personalis (NASDAQ:PSNL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends. Does the MarketBeat Community believe in CORBF or PSNL? Personalis received 125 more outperform votes than Global Cord Blood when rated by MarketBeat users. CompanyUnderperformOutperformGlobal Cord BloodN/AN/APersonalisOutperform Votes12568.31% Underperform Votes5831.69% Do analysts prefer CORBF or PSNL? Personalis has a consensus target price of $7.80, suggesting a potential upside of 103.66%. Given Personalis' stronger consensus rating and higher probable upside, analysts clearly believe Personalis is more favorable than Global Cord Blood.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Personalis 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CORBF or PSNL more profitable? Global Cord Blood has a net margin of 0.00% compared to Personalis' net margin of -104.52%. Global Cord Blood's return on equity of 0.00% beat Personalis' return on equity.Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Personalis -104.52%-66.07%-41.34% Which has preferable earnings & valuation, CORBF or PSNL? Global Cord Blood has higher revenue and earnings than Personalis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.65$79.04MN/AN/APersonalis$84.61M4.00-$108.30M-$1.37-2.80 Does the media refer more to CORBF or PSNL? In the previous week, Personalis had 4 more articles in the media than Global Cord Blood. MarketBeat recorded 4 mentions for Personalis and 0 mentions for Global Cord Blood. Personalis' average media sentiment score of 0.92 beat Global Cord Blood's score of 0.00 indicating that Personalis is being referred to more favorably in the news media. Company Overall Sentiment Global Cord Blood Neutral Personalis Positive Which has more volatility & risk, CORBF or PSNL? Global Cord Blood has a beta of -0.64, suggesting that its stock price is 164% less volatile than the S&P 500. Comparatively, Personalis has a beta of 1.89, suggesting that its stock price is 89% more volatile than the S&P 500. Do institutionals & insiders believe in CORBF or PSNL? 61.9% of Personalis shares are owned by institutional investors. 0.5% of Global Cord Blood shares are owned by company insiders. Comparatively, 3.8% of Personalis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryPersonalis beats Global Cord Blood on 10 of the 15 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$127.63M$1.93B$5.41B$18.86BDividend YieldN/A7.15%5.44%4.15%P/E RatioN/A15.4622.2332.41Price / Sales0.653.90398.0228.58Price / Cash1.409.3238.2017.53Price / BookN/A3.986.824.44Net Income$79.04M$87.49M$3.20B$1.02B7 Day PerformanceN/A8.14%5.78%3.35%1 Month Performance31.25%-7.73%-4.31%-5.48%1 Year Performance-16.00%-27.84%17.88%4.28% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$1.05+10.5%N/A-22.2%$127.63M$196.12M0.001,200Gap UpPSNLPersonalis3.8385 of 5 stars$3.24-1.2%$7.80+140.7%+194.6%$286.12M$84.61M-1.93400News CoverageVMDViemed Healthcare0.8236 of 5 stars$6.59-0.3%N/A-13.7%$261.24M$224.26M24.41630DCGODocGo2.9311 of 5 stars$2.35-1.7%$4.89+108.2%-36.9%$239.66M$616.56M8.392,920LFMDLifeMD2.1779 of 5 stars$5.13+2.0%$11.43+122.8%-45.7%$224.26M$212.45M-8.02230TOIOncology Institute0.275 of 5 stars$1.95+8.9%N/A+169.2%$147.34M$393.41M-2.50660High Trading VolumeSERASera Prognostics0.6351 of 5 stars$3.34+2.8%N/A-66.6%$122.41M$77,000.00-3.37120News CoverageGap DownAIRSAirSculpt Technologies1.0303 of 5 stars$1.78-2.5%$3.75+111.3%-67.7%$103.97M$180.35M-12.68240Upcoming EarningsNegative NewsGap DownHigh Trading VolumeEUDAEUDA Health0.6974 of 5 stars$4.10+7.3%N/A+106.7%$100.98M$3.81M0.002News CoveragePositive NewsQIPTQuipt Home Medical2.1077 of 5 stars$2.15+4.9%$6.25+190.7%-44.3%$88.34M$244.72M-12.65800BDSXBiodesix3.3901 of 5 stars$0.61+14.2%$2.95+387.6%-54.7%$88.32M$71.32M-1.55220News Coverage Related Companies and Tools Related Companies PSNL Competitors VMD Competitors DCGO Competitors LFMD Competitors TOI Competitors SERA Competitors AIRS Competitors EUDA Competitors QIPT Competitors BDSX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CORBF) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CORBF Stock Free CORBF Stock Alerts